Sankt Gertrauden-Krankenhaus
About Sankt Gertrauden-Krankenhaus
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Contego Medical, Inc.
2
Abbott Medical Devices
1
B. Braun Melsungen AG
1
Biotronik SE & Co. KG
1
Boston Scientific Corporation
1
Celgene
1
German Breast Group
1
Leiden University Medical Center
1
North Eastern German Society of Gynaecological Oncology
1
Pfm Medical Mepro Gmbh
1
Shockwave Medical, Inc.
1
Clinical Trials at Sankt Gertrauden-Krankenhaus
During the past decade, Sankt Gertrauden-Krankenhaus conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on
average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer
2007-11-01
2011-12-01
Completed
36
ProMRI AFFIRM Study of the EVIA/ENTOVIS Pacemaker With Safio S Pacemaker Leads
2012-03-01
2013-11-01
Completed
121
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
2013-09-26
2016-10-28
Completed
191
National, Multicenter PMS Study "Patient Reported Outcome" in Breast Reconstruction Following Mastectomy With TiLOOP Bra
2013-11-01
2021-06-01
Completed
267
Clinical Post Market Clinical Follow-up (PMCF) on Peripheral Arteries Treated With SeQuent® Please Over The Wire (OTW)
2015-05-01
2025-01-01
Active, not recruiting
960
A Multi-Center Study to Evaluate Acute Safety and Clinical Performance of Paladin® Carotid Post-Dilation Balloon System With Integrated Embolic Protection
2015-08-01
2016-10-01
Completed
106
Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery
2016-10-25
2025-04-01
Active, not recruiting
775
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
2017-02-22
2022-06-02
Completed
306
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sankt Gertrauden-Krankenhaus" #1 sponsor was "Contego Medical, Inc." with 2 trials, followed by "Abbott Medical Devices" with 1 trials
sponsored, "B. Braun Melsungen AG" with 1 trials sponsored, "Biotronik SE & Co. KG" with 1 trials sponsored and "Boston Scientific Corporation"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sankt Gertrauden-Krankenhaus"
#1 collaborator was "Bayer" with 1 trials as a collaborator, "Comprehensive Cancer Centre The Netherlands" with 1 trials as a collaborator, "Dutch Cancer Society" with 1 trials as a collaborator, "Institute of Clinical Cancer Research (IKF)" with 1 trials as a collaborator and "PharmaMar" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Sankt Gertrauden-Krankenhaus
According to Clinical.Site data, the most researched conditions in "Sankt Gertrauden-Krankenhaus" are
"Breast Cancer" (2 trials), "Peripheral Arterial Disease" (2 trials), "Arterial Occlusive Diseases" (1 trials), "Arteriosclerosis" (1 trials) and "Atherosclerosis" (1 trials). Many other conditions were trialed in "Sankt Gertrauden-Krankenhaus" in a lesser frequency.
Clinical Trials Intervention Types at Sankt Gertrauden-Krankenhaus
Most popular intervention types in "Sankt Gertrauden-Krankenhaus" are "Device" (8 trials), "Drug" (4 trials), "Procedure" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (1 trials), "Evia/Entovis pacemaker system under Magnetic Resonance Imaging (MRI) conditions" (1 trials), "External beam radiotherapy" (1 trials), "Gemcitabine" (1 trials) and "JETi Peripheral Thrombectomy System" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sankt Gertrauden-Krankenhaus
The vast majority of trials in "Sankt Gertrauden-Krankenhaus" are
8 trials for "All" genders and 5 trials for "Female" genders.
Clinical Trials Status at Sankt Gertrauden-Krankenhaus
Currently, there are NaN active trials in "Sankt Gertrauden-Krankenhaus".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Sankt Gertrauden-Krankenhaus,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sankt Gertrauden-Krankenhaus, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 4 trials that are defined as “Not Applicable".